The firm, a supplier of specialist contract fill and finish services, received £30,000 from the UK Trade and Investment (UKTI) which, according to SCM managing director Shirley Dann, will supplement global expansion plans.
Dann told Outsourcing-pharma that: “We will be using the grant to help us market to these new territories in terms of raising SCM Pharma’s profile, communicating our specialist services and generating enquiries.
“We will be looking to promote our services in the USA along with Northern and Western Europe. These territories have being identified as geographic markets with significant levels of R&D and include companies with needs that fit our offerings.”
Dann explained that the grant is a significant boost for the firm’s promotional efforts, adding that: “It will help us carry out activities that we might not have been able to do in order to help us raise awareness of SCM Pharma in new markets.”
She also said the award is recognition of SCM’s strength in “a niche area…in which we are offering specialist growing services such as the production of potent and radio-labelled products and products of biological origin we believe that these are in line with current market trends.”
UKTI international trade advisor Craig Daglish, who will work with SCM on a 10-month promotional campaign, predicted that the firm’s range of manufacturing services will be of significant interest to a number of pharma and biotech companies worldwide.